[HTML][HTML] Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis
Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
[PDF][PDF] di Indonesia
P Covid - Retrieved Februari, 19 - konsumen-cerdas.s3.ap-southeast-1 …
Puji dan syukur kami panjatkan kehadirat Tuhan Yang Maha Esa atas berkat dan karunia-
Nya sehingga BPOM dapat menyelesaikan penyusunan Informatorium Obat COVID-19 di …
Nya sehingga BPOM dapat menyelesaikan penyusunan Informatorium Obat COVID-19 di …
[HTML][HTML] Preclinical studies on convalescent human immune plasma-derived exosome: Omics and antiviral properties to SARS-CoV-2
The scale of the COVID-19 pandemic forced urgent measures for the development of new
therapeutics. One of these strategies is the use of convalescent plasma (CP) as a …
therapeutics. One of these strategies is the use of convalescent plasma (CP) as a …
How we secured a COVID‐19 convalescent plasma procurement scheme in Japan
M Terada, S Kutsuna, T Togano, S Saito… - …, 2021 - Wiley Online Library
Background In order to tackle the COVID‐19 pandemic, a COVID‐19 convalescent plasma
(CCP) procurement program was initiated in Japan in April 2020. The program was a …
(CCP) procurement program was initiated in Japan in April 2020. The program was a …
[PDF][PDF] Perplexing issues for convalescent immune plasma therapy in COVID-19.
O Ozdemir - Northern Clinics of Istanbul, 2021 - jag.journalagent.com
Perplexing issues for convalescent immune plasma therapy in COVID-19 Page 1 Oner
Ozdemir Division of Allergy and Immunology, Department of Pediatrics, Sakarya University …
Ozdemir Division of Allergy and Immunology, Department of Pediatrics, Sakarya University …
[PDF][PDF] THE ERA OF COVID-19: WILL CONVALESCENT PLASMA AND INTRAVENOUS IMMUNOGLOBULINS BE THE ANSWER
DA Aly, RM Kelany, A El-Rahman… - International Journal …, 2022 - researchgate.net
Since the World Health Organization (WHO) declared severe acute respiratory syndrome
corona virus-2 (SARS-CoV-2) infection a pandemic in December 2019, observational and …
corona virus-2 (SARS-CoV-2) infection a pandemic in December 2019, observational and …
A male Covid-19 convalescent plasma donor with long existence of SARS-Cov-2 antibodies: a case report
T Triyono, U Sukorini, A Christianalusi… - JKKI: Jurnal …, 2023 - journal.uii.ac.id
Abstract Covid-19 Convalescent Plasma (CCP) was one of alternative therapy for Covid-19
patients. The use of convalescent plasma as an adjunct therapy must consider its efficacy …
patients. The use of convalescent plasma as an adjunct therapy must consider its efficacy …
[PDF][PDF] COVID-19 Challenges And Associated Implemented Measures Of Blood Banks: A Systematic Review
KKS Amoguis, MEAT Booth, DB Caballero, KEAD Cruz… - researchgate.net
SARS-CoV-2 has presented many challenges ranging from health to economic issues. The
healthcare sector was particularly affected, straining its performance and resources. Blood …
healthcare sector was particularly affected, straining its performance and resources. Blood …
To which extent a convalescent plasma therapy could be a benefit for COVID-19 patients?
A Ali, A Abuelhassan, E Fawzi, A Albasher… - Journal of Ideas in …, 2020 - jidhealth.com
The emergence of an unprecedented pandemic SARS-COV-2 caused perplexed in the
medical community because of a high infection rate and rising mortality among COVID-19 …
medical community because of a high infection rate and rising mortality among COVID-19 …
[图书][B] ARDS in COVID-19-Insights for Treatment
K Ikuta, M Karin, Y Koyanagi - 2023 - books.google.com
The severe acute respiratory syndrome corona virus (SARS-CoV)-2 pandemic has had a
tremendous global impact. While most SARS-CoV-2 infections are mild, up to 20% of cases …
tremendous global impact. While most SARS-CoV-2 infections are mild, up to 20% of cases …